Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Cartalax cycle length: what human studies ran

Not approved — research use onlyDMechanistic only
Short answer: there is no established Cartalax cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Cartalax combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Cartalax cycle length?
No. We found no human studies that report a treatment duration for Cartalax.
What is the longest human study of Cartalax?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Cartalax dosing reference Full research page

References

  1. alanyl-glutamyl-aspartic acid [Supplementary Concept] — entry terms include Ala-Glu-Asp, cartalax and T-31 peptide Medical Subject Headings, U.S. National Library of Medicine. 2026
  2. Cartalax (CID 87815447) — compound record, C12H19N3O8, 333.29 g/mol, CAS 85806-95-7 PubChem, U.S. National Library of Medicine. 2026
  3. Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides Molecular Biology Reports. 2020
  4. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro Bulletin of Experimental Biology and Medicine. 2016
  5. Peptide Regulation of Cells Renewal Processes in Kidney Tissue Cultures from Young and Old Animals Bulletin of Experimental Biology and Medicine. 2015
  6. Tripeptides slow down aging process in renal cell culture (in Russian) Advances in Gerontology (Uspekhi Gerontologii). 2014
  7. Peptidergic regulation of thymocyte differentiation, proliferation, and apoptosis during aging of the thymus Bulletin of Experimental Biology and Medicine. 2011
  8. Effect of short peptides on neuronal differentiation of stem cells International Journal of Immunopathology and Pharmacology. 2019
  9. ClinicalTrials.gov registry query for "cartalax" (the single returned record is an unrelated enteral-nutrition study retrieved by fuzzy matching) ClinicalTrials.gov (U.S. National Library of Medicine). 2026
  10. openFDA Drug Label API query for "cartalax" (no approved human drug labeling returned) U.S. Food and Drug Administration / openFDA. 2026
  11. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026) U.S. Food and Drug Administration. 2026
  12. World Anti-Doping Code International Standard — Prohibited List 2026 (effective 1 January 2026) World Anti-Doping Agency. 2026
  13. PubMed query for "cartalax" (6 records, all retrieved through the MeSH mapping of the name to the tripeptide Ala-Glu-Asp) PubMed / NCBI Entrez (U.S. National Library of Medicine). 2026